Evidence map›Paper›PMID 32410773›Full record

GuidelineRevue des maladies respiratoires2020

[Guide for follow-up of patients with SARS-CoV-2 pneumonia. Management proposals developed by the French-language Respiratory Medicine Society. Version of 10 May 2020].

C Andrejak, F-X Blanc, F Costes, B Crestani, D Debieuvre, T Perez, B Philippe, L Plantier, F Schlemmer, L Sesé and 6 more

Open access · bronzeAbstract readPractice Guideline
In one paragraph

Guideline in Revue des maladies respiratoires, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Revue des maladies respiratoires actualites · 2021
    Article
  8. Nondyspnogenic acute hypoxemic respiratory failure in COVID-19 pneumonia.Journal of applied physiology (Bethesda, Md. : 1985) · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 1 country.

C AndrejakService de pneumologie, UR 4294 AGIR, université Picardie Jules-Verne, CHU Amiens-Picardie, rond point Christian-Chabrol, 80054 Amiens, France. Electronic address: andrejak.claire@chu-amiens.fr.
F-X BlancService de pneumologie, l'institut du thorax, université de Nantes, CHU de Nantes, 44093 Nantes, France.
F CostesService de médecine du sport et explorations fonctionnelles, INRAE, UNH, université Clermont Auvergne, CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France.
B CrestaniInserm 1152, service de pneumologie, hôpital Bichat, université de Paris, 75108 Paris, France.
D DebieuvreService de pneumologie, groupe hospitalier de la région Mulhouse Sud-Alsace, hôpital Émile-Muller, Mulhouse, France.
T PerezService d'explorations fonctionnelles respiratoires, clinique des maladies respiratoires, CHU de Lille, 59000 Lille, France.
B PhilippeService de pneumologie, centre hospitalier René-Dubos, 95300 Pontoise, France.
L PlantierCEPR, Inserm UMR1100, service de pneumologie et explorations fonctionnelles respiratoires, université de Tours, CHRU de Tours, 37000 Tours, France.
F SchlemmerUnité de pneumologie, hôpitaux universitaires Henri-Mondor, université Paris Est Créteil, Assistance publique-Hôpitaux de Paris, 94000 Créteil, France.
L SeséService de physiologie, hôpital Avicenne, Assistance publique-Hôpitaux de Paris, 93000 Bobigny, France.
B StachCabinet médical Saint-Michel, 59300 Valenciennes, France.
Y UzunhanInserm U1272, service de pneumologie, laboratoire « hypoxie et poumon », hôpital Avicenne, université Paris Nord, Bobigny, France.
C ZanettiCabinet médical, 20, avenue Raoul-Briquet, 62300 Lens, France.
M ZysmanInserm 1045 équipe 2, service des maladies respiratoires, CHU de Bordeaux, 33000 Bordeaux, France.
C RaherisonU1219 Epicene, service des maladies respiratoires, université de Bordeaux, CHU de Bordeaux, Bordeaux, France.
B MaitreUnité de pneumologie, hôpitaux universitaires Henri-Mondor, université Paris Est Créteil, Assistance publique-Hôpitaux de Paris, 94000 Créteil, France.
Inserm · FRCentre Hospitalier Universitaire Henri-Mondor · FRAgents infectieux, résistance et chimiothérapie · FRCentre Hospitalier de Mulhouse · FRCentre Hospitalier René-Dubos · FRCentre Hospitalier Universitaire de Lille · FRHôpital Avicenne · FRHôpital Saint-Michel · FRInstitut du Thorax · FRUnité de Nutrition Humaine · FRUniversité de Bordeaux · FRUniversité de Tours · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The French-language Respiratory Medicine Society (SPLF) proposes a guide for the follow-up of patients who have presented with SARS-CoV-2 pneumonia. The proposals are based on known data from previous epidemics, on acute lesions observed in SARS-CoV-2 patients and on expert opinion. This guide proposes a follow-up based on three categories of patients: (1) patients managed outside hospital for possible or proven SARS-CoV-2 infection, referred by their physician for persistent dyspnoea; (2) patients hospitalized for SARS-CoV-2 pneumonia in a medical unit; (3) patients hospitalized for SARS-CoV-2 pneumonia in an intensive care unit. The subsequent follow-up will have to be adapted to the initial assessment. This guide emphasises the possibility of others causes of dyspnoea (cardiac, thromboembolic, hyperventilation syndrome…). These proposals may evolve over time as more knowledge becomes available.

Indexed as

AftercareAmbulatory CareCardiovascular DiseasesCoronavirus InfectionsCOVID-19Critical CareDiagnostic Techniques, Respiratory SystemDisease ManagementEmergency Medical ServicesHealth PrioritiesHospitalizationHumansInpatientsOutpatientsPandemicsPneumonia, ViralCOVIDCT scanFibroseFibrosisFollow-upPléthysmographiePlethysmographyScannerSuivi

Identifiers

PMID32410773
PMCPMC7221358
OpenAlexW3025031353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.